← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2020Last known activity
Jun 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 14 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (35)
- NCT07259512Sponsor investigatorPhase 4Jun 30, 2025
- NCT07259512Lead sponsorPhase 4Jun 30, 2025
- NCT06615674Sponsor investigatorPhase 4Sep 21, 2024
- NCT06615674Lead sponsorPhase 4Sep 21, 2024
- NCT06871358Sponsor investigatorN/ASep 1, 2024
- NCT06871358Lead sponsorN/ASep 1, 2024
- NCT07075289Lead sponsorPhase 4Apr 1, 2024
- NCT07075289Sponsor investigatorPhase 4Apr 1, 2024
- NCT05834647Overall official - principal investigatorPhase 4Aug 1, 2023
- NCT05834647OfficialPhase 4Aug 1, 2023
- NCT05834647Lead sponsorPhase 4Aug 1, 2023
- NCT05834647Sponsor investigatorPhase 4Aug 1, 2023
- NCT05834647Reponsible party - principal investigatorPhase 4Aug 1, 2023
- NCT05618223Lead sponsorPhase 3Dec 1, 2022
- NCT05618223Overall official - principal investigatorPhase 3Dec 1, 2022
Details
- Last known activity
- Jun 30, 2025